Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
Ticker SymbolMMSI
Company nameMerit Medical Systems Inc
IPO dateSep 16, 1954
Founded at1987
CEO- -
Number of employees7400
Security typeOrdinary Share
Fiscal year-endSep 16
Address1600 West Merit Park Way
CitySOUTH JORDAN
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code84095
Phone18012531600
Websitehttps://www.merit.com/
Ticker SymbolMMSI
IPO dateSep 16, 1954
Founded at1987
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data